Sofinnova Investments as of June 30, 2021
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 67 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Natera Comm (NTRA) | 20.3 | $352M | 3.1M | 113.53 | |
Karuna Therapeutics Comm | 12.8 | $223M | 2.0M | 113.99 | |
Aerovate Therapeutics Comm (AVTE) | 4.9 | $86M | 3.8M | 22.83 | |
Y-mAbs Therapeutics Comm (YMAB) | 4.3 | $74M | 2.2M | 33.80 | |
Ascendis Pharma A/S Adr (ASND) | 4.0 | $69M | 522k | 131.55 | |
AstraZeneca Adr (AZN) | 3.3 | $58M | 960k | 59.90 | |
iShares TR iShares Biotech Put Option | 3.1 | $53M | 325k | 163.65 | |
Bolt Biotherapeutics Comm (BOLT) | 2.5 | $43M | 2.8M | 15.46 | |
United Therapeutics Corp Comm (UTHR) | 2.2 | $39M | 216k | 179.41 | |
Vera Therapeutics Cl A (VERA) | 2.2 | $39M | 2.9M | 13.26 | |
Biogen Comm (BIIB) | 2.2 | $38M | 111k | 346.27 | |
Inozyme Pharma Comm (INZY) | 2.0 | $35M | 2.0M | 17.04 | |
Galera Therapeutics Comm (GRTX) | 1.7 | $30M | 3.1M | 9.83 | |
Acceleron Pharma Comm | 1.7 | $29M | 234k | 125.49 | |
Align Technology Comm (ALGN) | 1.7 | $29M | 47k | 611.00 | |
PTC Therapeutics Comm (PTCT) | 1.4 | $25M | 582k | 42.27 | |
Insmed Comm (INSM) | 1.4 | $24M | 844k | 28.46 | |
Sarepta Therapeutics Comm (SRPT) | 1.3 | $23M | 299k | 77.74 | |
Ark Etf Tr Genomic Rev ETF Put Option | 1.3 | $23M | 250k | 92.50 | |
Heron Therapeutics Comm (HRTX) | 1.3 | $23M | 1.5M | 15.52 | |
Checkmate Pharmaceuticals Comm | 1.2 | $22M | 3.6M | 5.96 | |
Nextcure Comm (NXTC) | 1.2 | $22M | 2.7M | 8.03 | |
Protagonist Therapeutics Comm (PTGX) | 1.2 | $20M | 449k | 44.88 | |
Neurocrine Biosciences Comm (NBIX) | 1.1 | $20M | 203k | 97.32 | |
Exelixis Comm (EXEL) | 1.1 | $20M | 1.1M | 18.22 | |
Akouos Comm | 1.1 | $19M | 1.5M | 12.55 | |
Insulet Corp Comm (PODD) | 1.1 | $19M | 69k | 274.51 | |
Vertex Pharmaceuticals Comm (VRTX) | 1.0 | $18M | 88k | 201.63 | |
Regenxbio Comm (RGNX) | 1.0 | $17M | 428k | 38.85 | |
Nucana Biomed Adr (NCNA) | 0.9 | $16M | 5.6M | 2.77 | |
Agenus Comm (AGEN) | 0.9 | $15M | 2.8M | 5.49 | |
Dexcom Comm (DXCM) | 0.8 | $14M | 34k | 426.99 | |
ObsEva SA Comm | 0.8 | $14M | 4.7M | 3.03 | |
Intra-Cellular Therapies Comm (ITCI) | 0.7 | $13M | 313k | 40.82 | |
Mirati Therapeutics Comm | 0.7 | $13M | 79k | 161.53 | |
Agios Pharmaceuticals Comm (AGIO) | 0.7 | $12M | 219k | 55.11 | |
Reata Pharmaceuticals Comm | 0.6 | $11M | 80k | 141.53 | |
Uniqure NV Comm (QURE) | 0.6 | $10M | 324k | 30.80 | |
Amgen Comm (AMGN) | 0.6 | $9.9M | 41k | 243.75 | |
Cytokinetics Comm (CYTK) | 0.5 | $9.5M | 481k | 19.79 | |
Kura Oncology Comm (KURA) | 0.5 | $9.3M | 444k | 20.85 | |
Nucana Biomed Ordinary Shares | 0.4 | $6.6M | 2.4M | 2.77 | |
MacroGenics Comm (MGNX) | 0.4 | $6.3M | 235k | 26.86 | |
ChemoCentryx Comm | 0.4 | $6.2M | 466k | 13.39 | |
Marinus Pharmaceuticals Comm (MRNS) | 0.4 | $6.2M | 346k | 17.94 | |
Coherus BioSciences Comm (CHRS) | 0.3 | $6.0M | 435k | 13.83 | |
Cyteir Therapeutics Comm | 0.3 | $5.7M | 265k | 21.40 | |
FibroGen Comm Put Option | 0.3 | $5.3M | 200k | 26.63 | |
Immatics NV Comm (IMTX) | 0.3 | $5.1M | 443k | 11.61 | |
Amarin Corp Adr (AMRN) | 0.3 | $5.1M | 1.2M | 4.38 | |
TCR2 Therapeutics Comm | 0.3 | $4.9M | 296k | 16.41 | |
Celldex Therapeutics Comm (CLDX) | 0.3 | $4.5M | 135k | 33.44 | |
Mirum Pharmaceuticals Comm (MIRM) | 0.3 | $4.5M | 260k | 17.29 | |
Jounce Therapeutics Comm | 0.2 | $4.2M | 625k | 6.80 | |
Fate Therapeutics Comm (FATE) | 0.2 | $4.0M | 46k | 86.79 | |
Aligos Therapeutics Comm (ALGS) | 0.2 | $3.3M | 164k | 20.38 | |
ChemoCentryx Comm Call Option | 0.2 | $2.9M | 215k | 13.39 | |
Otonomy Comm | 0.2 | $2.8M | 1.3M | 2.23 | |
Replimune Group Comm (REPL) | 0.2 | $2.8M | 72k | 38.42 | |
BioCryst Pharmaceuticals Comm (BCRX) | 0.1 | $2.5M | 159k | 15.81 | |
ACADIA Pharmaceuticals Comm Call Option | 0.1 | $2.4M | 100k | 24.39 | |
TCR2 Therapeutics Comm Put Option | 0.1 | $2.3M | 140k | 16.41 | |
Synlogic Comm | 0.1 | $2.2M | 575k | 3.89 | |
Savara Comm (SVRA) | 0.1 | $2.2M | 1.3M | 1.70 | |
PDS Biotechnology Corporation Comm (PDSB) | 0.1 | $1.8M | 143k | 12.55 | |
CTI BioPharma Corp Comm | 0.0 | $429k | 172k | 2.50 | |
Sierra Oncology Comm | 0.0 | $49k | 2.5k | 19.60 |